Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lapucci

Showing results (221-230 of 234) with videos related to

Pageof 24
Sort By:
Plos One|November 28, 2018
Workload measurement for molecular genetics laboratory: A survey studyEnrico Tagliafico, Isabella Bernardis, Marina Grasso, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|August 6, 2020
Tailoring B cell depletion therapy in MS according to memory B cell monitoringGiovanni Novi, Francesca Bovis, Sabrina Fabbri, et al.
European Journal of Neurology|November 28, 2025
Machine Learning Analysis Applied to Prediction of Early Progression Independent of Relapse Activity in Multiple Sclerosis PatientsValentina Poretto, Walter Endrizzi, Matteo Betti, et al.
Seminars in Arthritis and Rheumatism|March 2, 2021
Comprehensive disease control in systemic lupus erythematosusFulvia Ceccarelli, Giulio Olivieri, Alessio Sortino, et al.
Journal of Neurology|June 19, 2019
Outcomes after fingolimod to alemtuzumab treatment shift in relapsing-remitting MS patients: a multicentre cohort studyJessica Frau, Francesco Saccà, Alessio Signori, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|March 7, 2020
Impact of treatment on cellular immunophenotype in MS: A cross-sectional studyMaria Cellerino, Federico Ivaldi, Matteo Pardini, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 15, 2024
Ocrelizumab in MS patients with persistence of disease activity after alemtuzumab: A multi-center Italian studyCaterina Lapucci, Jessica Frau, Eleonora Cocco, et al.
European Journal of Neurology|December 10, 2019
Subgroup comparison according to clinical phenotype and serostatus in autoimmune encephalitis: a multicenter retrospective studyM Gastaldi, S Mariotto, M P Giannoccaro, et al.
Radiology|February 7, 2023
Multicenter Evaluation of AI-generated DIR and PSIR for Cortical and Juxtacortical Multiple Sclerosis Lesion DetectionPiet M Bouman, Samantha Noteboom, Fernando A Nobrega Santos, et al.
European Journal of Neurology|September 24, 2021
A real-world study of alemtuzumab in a cohort of Italian patientsCinzia Valeria Russo, Francesco Saccà, Jessica Frau, et al.
Pageof 24

Showing results (221-230 of 234) with videos related to

Sort By:
Pageof 24
Plos One|November 28, 2018
Workload measurement for molecular genetics laboratory: A survey studyEnrico Tagliafico, Isabella Bernardis, Marina Grasso, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|August 6, 2020
Tailoring B cell depletion therapy in MS according to memory B cell monitoringGiovanni Novi, Francesca Bovis, Sabrina Fabbri, et al.
European Journal of Neurology|November 28, 2025
Machine Learning Analysis Applied to Prediction of Early Progression Independent of Relapse Activity in Multiple Sclerosis PatientsValentina Poretto, Walter Endrizzi, Matteo Betti, et al.
Seminars in Arthritis and Rheumatism|March 2, 2021
Comprehensive disease control in systemic lupus erythematosusFulvia Ceccarelli, Giulio Olivieri, Alessio Sortino, et al.
Journal of Neurology|June 19, 2019
Outcomes after fingolimod to alemtuzumab treatment shift in relapsing-remitting MS patients: a multicentre cohort studyJessica Frau, Francesco Saccà, Alessio Signori, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|March 7, 2020
Impact of treatment on cellular immunophenotype in MS: A cross-sectional studyMaria Cellerino, Federico Ivaldi, Matteo Pardini, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 15, 2024
Ocrelizumab in MS patients with persistence of disease activity after alemtuzumab: A multi-center Italian studyCaterina Lapucci, Jessica Frau, Eleonora Cocco, et al.
European Journal of Neurology|December 10, 2019
Subgroup comparison according to clinical phenotype and serostatus in autoimmune encephalitis: a multicenter retrospective studyM Gastaldi, S Mariotto, M P Giannoccaro, et al.
Radiology|February 7, 2023
Multicenter Evaluation of AI-generated DIR and PSIR for Cortical and Juxtacortical Multiple Sclerosis Lesion DetectionPiet M Bouman, Samantha Noteboom, Fernando A Nobrega Santos, et al.
European Journal of Neurology|September 24, 2021
A real-world study of alemtuzumab in a cohort of Italian patientsCinzia Valeria Russo, Francesco Saccà, Jessica Frau, et al.
Pageof 24